1. Home
  2. GS vs AZN Comparison

GS vs AZN Comparison

Compare GS & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goldman Sachs Group Inc. (The)

GS

Goldman Sachs Group Inc. (The)

HOLD

Current Price

$893.62

Market Cap

237.2B

Sector

Finance

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$91.20

Market Cap

276.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GS
AZN
Founded
1869
1992
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
237.2B
276.3B
IPO Year
1999
1993

Fundamental Metrics

Financial Performance
Metric
GS
AZN
Price
$893.62
$91.20
Analyst Decision
Hold
Strong Buy
Analyst Count
14
2
Target Price
$748.77
N/A
AVG Volume (30 Days)
2.1M
5.7M
Earning Date
01-14-2026
11-06-2025
Dividend Yield
1.80%
1.71%
EPS Growth
44.63
45.02
EPS
49.26
6.02
Revenue
$57,337,000,000.00
$58,127,000,000.00
Revenue This Year
$16.38
$11.33
Revenue Next Year
$5.30
$6.08
P/E Ratio
$18.03
$14.93
Revenue Growth
16.10
13.52
52 Week Low
$439.38
$61.24
52 Week High
$919.10
$94.02

Technical Indicators

Market Signals
Indicator
GS
AZN
Relative Strength Index (RSI) 68.67 57.49
Support Level $808.30 $89.28
Resistance Level $919.10 $91.66
Average True Range (ATR) 19.15 1.29
MACD 7.40 -0.34
Stochastic Oscillator 81.83 40.97

Price Performance

Historical Comparison
GS
AZN

About GS Goldman Sachs Group Inc. (The)

Goldman Sachs is a storied financial institution, founded in 1869 and best known for its role as a leading global investment bank. The firm has a sprawling reach across global financial centers and has been the leading provider of global merger and acquisition advisory services, by revenue, for the past 20 years. Since the global financial crisis, Goldman has expanded its offerings into more stable fee-based businesses like asset and wealth management, which comprised roughly 30% of post-provision revenue at the end of 2024. The bank holding company generates revenue from investment banking, global market making and trading, lending, asset management, wealth management, and a small and declining portfolio of consumer credit card loans.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Share on Social Networks: